Pharma Pulse: HHS Updates Menopausal Hormone Therapy Labels, as SGLT2 Inhibitors Show Broader Kidney and Heart Benefits

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and in today’s headlines, HHS announces a label change for menopausal hormone therapies or hormone replacement therapies following an FDA request, researchers look to uncover both the relative and absolute effects of SGLT2is, and Arsenal Capital Partners acquires ThermoSafe.

• The Department of Health and Human Services (HHS) has announced a major labeling update for menopausal hormone therapy. HHS is removing outdated and misleading safety warnings that overstated risks such as breast cancer and heart disease. The agency said the revised labels will better reflect current evidence, which shows that for many women, hormone therapy can be a safe and effective treatment for menopausal symptoms when used appropriately.
• In clinical research news, a new analysis highlights the significant benefits of SGLT2 inhibitors in improving kidney health and reducing hospitalizations and mortality. The findings underscore the broad utility of this class beyond diabetes management, suggesting strong protective effects for patients with chronic kidney disease and heart failure, further solidifying SGLT2 inhibitors’ role as a cornerstone therapy in cardio-renal-metabolic care.
• And in the biopharma manufacturing sector, Arsenal Capital Partners has completed its acquisition of ThermoSafe, a provider of temperature-controlled packaging solutions. The move expands Arsenal’s life sciences logistics portfolio, supporting the growing demand for cold chain capabilities as biologics and cell and gene therapies become more prominent in global supply chains.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.